Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Scott

Showing results (291-300 of 316) with videos related to

Pageof 32
Sort By:
Rheumatology (Oxford, England)|November 3, 2005
Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British Rheumatoid Outcome Study Group randomized controlled clinical trialD Symmons, K Tricker, M Harrison, et al.
Clinical and Experimental Immunology|July 3, 2013
Enhanced and persistent levels of interleukin (IL)-17⁺ CD4⁺ T cells and serum IL-17 in patients with early inflammatory arthritisN J Gullick, H S Abozaid, D M Jayaraj, et al.
Calcified Tissue International|January 1, 1984
Divergent effects of forskolin on 3',5' cyclic adenosine monophosphate production and parathyroid hormone secretionL K Cantley, D L Scott, C W Cooper, et al.
Annals of the Rheumatic Diseases|April 1, 1984
Lymphoproliferative malignancy in rheumatoid arthritis: a study of 20 casesD P Symmons, M Ahern, P A Bacon, et al.
Science (New York, N.Y.)|September 8, 2001
Crystal structure of the extracellular segment of integrin alpha Vbeta3J P Xiong, T Stehle, B Diefenbach, et al.
Clinical Rheumatology|December 1, 1986
Takayasu's arteritis: a pathogenetic role for cytotoxic T lymphocytes?D G Scott, M Salmon, D L Scott, et al.
Pharmacoeconomics|July 6, 1998
Choice of NSAID and management strategy in rheumatoid arthritis and osteoarthritis. The impact on costs and outcomes in the UKC J McCabe, R L Akehurst, J Kirsch, et al.
Journal of Molecular Biology|August 25, 1995
The 2.4 A crystal structure of cholera toxin B subunit pentamer: choleragenoidR G Zhang, M L Westbrook, E M Westbrook, et al.
Lancet (London, England)|February 3, 1999
Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study GroupJ S Smolen, J R Kalden, D L Scott, et al.
Rheumatology (Oxford, England)|February 1, 2007
The overall status in rheumatoid arthritis (OSRA) measure--further evidence to support its use in clinical practiceM J Harrison, A Hassell, P T Dawes, et al.
Pageof 32

Showing results (291-300 of 316) with videos related to

Sort By:
Pageof 32
Rheumatology (Oxford, England)|November 3, 2005
Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British Rheumatoid Outcome Study Group randomized controlled clinical trialD Symmons, K Tricker, M Harrison, et al.
Clinical and Experimental Immunology|July 3, 2013
Enhanced and persistent levels of interleukin (IL)-17⁺ CD4⁺ T cells and serum IL-17 in patients with early inflammatory arthritisN J Gullick, H S Abozaid, D M Jayaraj, et al.
Calcified Tissue International|January 1, 1984
Divergent effects of forskolin on 3',5' cyclic adenosine monophosphate production and parathyroid hormone secretionL K Cantley, D L Scott, C W Cooper, et al.
Annals of the Rheumatic Diseases|April 1, 1984
Lymphoproliferative malignancy in rheumatoid arthritis: a study of 20 casesD P Symmons, M Ahern, P A Bacon, et al.
Science (New York, N.Y.)|September 8, 2001
Crystal structure of the extracellular segment of integrin alpha Vbeta3J P Xiong, T Stehle, B Diefenbach, et al.
Clinical Rheumatology|December 1, 1986
Takayasu's arteritis: a pathogenetic role for cytotoxic T lymphocytes?D G Scott, M Salmon, D L Scott, et al.
Pharmacoeconomics|July 6, 1998
Choice of NSAID and management strategy in rheumatoid arthritis and osteoarthritis. The impact on costs and outcomes in the UKC J McCabe, R L Akehurst, J Kirsch, et al.
Journal of Molecular Biology|August 25, 1995
The 2.4 A crystal structure of cholera toxin B subunit pentamer: choleragenoidR G Zhang, M L Westbrook, E M Westbrook, et al.
Lancet (London, England)|February 3, 1999
Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study GroupJ S Smolen, J R Kalden, D L Scott, et al.
Rheumatology (Oxford, England)|February 1, 2007
The overall status in rheumatoid arthritis (OSRA) measure--further evidence to support its use in clinical practiceM J Harrison, A Hassell, P T Dawes, et al.
Pageof 32